Decoding Covid 19

[futureofandhra]

• Ever since this virus broke out no one is ready to take on this pandemic and that's history 
• Since this is collaborated effort from entire world it is going to be tough task to eliminate this virus completely.
• Prediction is by September 2021 this virus may come under control

Coming to solution after new variants started flourishing 

1. Wear masks and keep maintain social distance even if you are vaccinated.

Skepticism on vaccine

• No one has any clue on how each vaccine is effecting anyone especially with body reactions 
• Heard doctors contracted this virus even after they are vaccinated

Vaccine Info

• No clear statistics on this vaccines  trails are done at different time periods
• J&J & Astro vaccine are recent and they might have been tried on new variants(Type Adenovirus)
• Pfizer & Moderna are the first 2 vaccines' that came out(mRNA)
• Astrozenca seems causing blood clots but not sure about it 100%
• Moderna seems giving more allergies compared to others but it has 95% effective ness after 2 doses and interestingly 92% after 1 dose after 14 days
• Pfizer 52% after first dose and 94% after the second dose
• Astrozenca found to be 81% but it requires 2 doses
• J&J seems 72%

Pasting pictures below to show some statistics am not 100% sure if this is right or wrong just giving info 

 

Hope it helps AFDB family

Regards

FutureofAndhra

[futureofandhra]

Sources of my summary

https://youtu.be/6Zq_Y2rV4PI
https://youtu.be/V4cyYvmU5Cc

[bhaigan]

Thanks for the info

[Epic]

Min enni months/years protection guaranteed ane info undha Veetiki?

[cellphone]

z1 z2 enti ? ardam ithaley

[futureofandhra]

1 minute ago, cellphone said:

z1 z2 enti ? ardam ithaley

dose1 dose2

[futureofandhra]

7 minutes ago, Epic said:

Min enni months/years protection guaranteed ane info undha Veetiki?

just protection ani chepparu duration ivvaledhu 

 

[bhaigan]

this is also very informative

 

[futureofandhra]

@Amrita seems you may not need 2nd dose n Moderna has more allergical reaction it seems and dosage also high

[Amrita]

4 minutes ago, futureofandhra said:

@Amrita seems you may not need 2nd dose n Moderna has more allergical reaction it seems and dosage also high

I am not really sure if I have to take it . We are due for second dose in a week . My doctor says it’s ok take second dose and be completely vaccinated. I am scared honestly. 

Future lo travel ki vaccination cards use cheste na paristhithi enti with only one dose all these are open questions I have no answers for . 

[futureofandhra]

Just now, Amrita said:

I am not really sure if I have to take it . We are due for second dose in a week . My doctor says it’s ok take second dose and be completely vaccinated. I am scared honestly. 

As per that data Moderna after 14 days of first dose gives 92% efficacy 

you can check the data

[Amrita]

3 minutes ago, futureofandhra said:

As per that data Moderna after 14 days of first dose gives 92% efficacy 

you can check the data

Moderna: at least 80%

Moderna's vaccine was 69.5% effective at preventing COVID-19 with symptoms between the first and second dose, with a true value between 43.5% and 84.5%. There was a fairly wide range because the number of people that caught COVID-19 in the trial during this time period was low.

The 69.5% figure includes the 13 days before protection starts, so the real percentage could be higher.

There were a small number of people in Moderna's trial — about 7%  — that didn't get their second dose for unknown reasons. In this group, the shot was 50.8% effective at preventing COVID-19 with symptoms for up to 14 days after the first dose and 92.1% effective after 14 days.

It is unclear how well one shot of the vaccine protects against hospitalization and death because not many people got severe COVID-19 — two in the vaccine group and four in placebo. 

Evans said that you get at least 80% protection — and probably better than 90% — for Moderna's vaccine against COVID-19 with symptoms after a single dose for 28 days. After 28 days it was unclear because it hadn't been tested. Again, this was based on his overall reading of the FDA data, he said.

[futureofandhra]

2 minutes ago, Amrita said:

Moderna: at least 80%

Moderna's vaccine was 69.5% effective at preventing COVID-19 with symptoms between the first and second dose, with a true value between 43.5% and 84.5%. There was a fairly wide range because the number of people that caught COVID-19 in the trial during this time period was low.

The 69.5% figure includes the 13 days before protection starts, so the real percentage could be higher.

There were a small number of people in Moderna's trial — about 7%  — that didn't get their second dose for unknown reasons. In this group, the shot was 50.8% effective at preventing COVID-19 with symptoms for up to 14 days after the first dose and 92.1% effective after 14 days.

It is unclear how well one shot of the vaccine protects against hospitalization and death because not many people got severe COVID-19 — two in the vaccine group and four in placebo. 

Evans said that you get at least 80% protection — and probably better than 90% — for Moderna's vaccine against COVID-19 with symptoms after a single dose for 28 days. After 28 days it was unclear because it hadn't been tested. Again, this was based on his overall reading of the FDA data, he said.

on what date this info you took from

[Amrita]

1 minute ago, futureofandhra said:

on what date this info you took from

I didn’t pay attention . Last week anukunta. Each link also have random info . I am not really sure whom to believe . My doctor himself told take second shot when CDC told not to . Evarini nammali? I feel no one has clarity . I might take second dose . Just for sake of finishing the vaccination dose . 

[Sachin200]

South African COVID-19 strain can 'break through' vaccine: researchers

An Israeli study released on Saturday found that the coronavirus variant first detected in South Africa is able to "break through" the antibodies created from the Pfizer-BioNTech vaccine to some extent.

 

The variant, B.1.351, was found in 1 percent of all people studied, but its prevalence rate was eight times higher among those who received two doses of the vaccine than among those who were unvaccinated, at 5.4 percent and 0.7 percent, respectively.

"We found a disproportionately higher rate of the South African variant among people vaccinated with a second dose, compared to the unvaccinated group. This means that the South African variant is able, to some extent, to break through the vaccine's protection," Tel Aviv University researcher Adi Stern said, according to Reuters.